Walleye Trading
FOMX

Walleye Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Walleye Trading’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-18,533
Closed -$67K – 5060
2018
Q4 		$67K Sell
18,533
-79,453
-81% -$346K ﹤0.01% 4045
2018
Q3 		$561K Buy
+97,986
New +$561K ﹤0.01% 2769

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Walleye Trading's FOMX Position: Q1 2019 in Review

Walleye Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2019, closing a stake of 18,533 shares — an estimated $67K sold.

Walleye Trading first reported a position in FOMX in Q3 2018 and held it in 2 quarters. The position peaked at $561K in Q3 2018. 62 funds tracked by Wall St. Rank hold FOMX as of Q1 2019.

  • Walleye Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Walleye Trading sold 18,533 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2019, an estimated $67K.
  • Walleye Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2018 and held it in 2 quarters.
  • Walleye Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $561K in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2019.

Based on Walleye Trading's 13F filing for Q1 2019, filed 15 May 2019.